| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVR | EVERCORE INC | B | $267.19 | C | $210.06 | 27.20% | 17.47x | 14.40x | 2.68x | 5.21x | 0.76x | $1.18B | 11.43% | $2.03B | 52.48 | $10.31B | 12.80 |
| EVER | EVERQUOTE INC | A | $16.22 | A | $15.43 | 5.11% | 5.90x | 8.34x | 0.85x | 2.46x | 70.18x | $90.32M | 15.41% | $238.04M | 6.59 | $415.59M | 6.33 |
| TPR | TAPESTRY INC | B | $142.67 | C | $57.20 | 149.42% | 52.84x | 21.74x | 3.87x | 52.40x | 1.21x | $1.64B | 5.64% | $551.20M | 2.70 | $31.78B | 33.79 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | $8.38 | A | N/A | N/A | 6.65x | 21.31x | 2.01x | -17.64x | N/A | $344.90M | 19.61% | -$119.15M | -0.57 | $2.49B | 7.16 |
| DDS | DILLARD's INC | B | $573.77 | B | N/A | N/A | 15.61x | 16.97x | 1.35x | 4.38x | N/A | $789.04M | 8.81% | $2.05B | 130.98 | $8.36B | 9.48 |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More